Ohhhhh what you get

My prediction is the biotech job market is cyclical and will rebound, but offshoring of entry level jobs and an ascendant Chinese biotech system will blunt that recovery here. This will be countered over the longer term by smaller PhD cohorts and fewer grads which we are starting to see (overdue).

A few hundred applicants in this market is probably a baseline.

I have heard of senior scientist positions at pharma companies, which are entry level industry roles for people with Ph.D + postdoc, getting 1000. It’s a mess.

Game is amazing just stop mumbling

Eric those days are long over and I’m sorry

Haven’t seen a rolo or watchamacallit in ten years

Butterfingers will be next if the payday and hundred grand are critically endangered then butterfingers are a threatened species

We should catch up I think about you often and how you are doing

Synthetic non-canonical amino acids or gtfo

This is so obvious in hindsight yet I hadn’t considered the evolutionary pressure against lysines in this context. Do you know if WNK ( with no lysine) family kinases are involved in regulating quality control?